Results 21 to 30 of about 12,750 (218)

The serum levels and clinical significance of interleukin-33 and soluble ST2 in patients with vitiligo

Pifu-xingbing zhenliaoxue zazhi, 2020
Objective: To investigate the clinical significance of interleukin-33(IL-33) and soluble ST2 (sST2) in patients with vitiligo. Methods: The serum concentrations of IL-33 and sST2 were determined by enzyme linked immunosorbent assay (ELISA) respectively ...
Li YANG, Dong-qing LU, Han MA
doaj   +1 more source

Analytical performances of a new rapid assay of soluble ST2 for cardiac and inflammatory diseases and establishment of the reference intervals for children and adolescence in China

Practical Laboratory Medicine, 2023
Background: sST2 has emerged as a potential disease biomarker of cardiac and inflammatory diseases in pediatrics. This study aimed to evaluate the performance of the new Pylon sST2 assay and establish the reference intervals of sST2 in children and ...
Zhicheng Ye, Chuanshu Chen, Shiwei Chen, Menghua Xu, Jin Xu   +4 more
doaj   +1 more source

STADE‐HF (sST2 As a help for management of HF): a pilot study

ESC Heart Failure, 2020
Aims Biomarkers are not recommended until now to guide the management of patients with heart failure (HF). Soluble suppression of tumorigenicity 2 (sST2) appears as a promising biomarker. The current study considered pre‐discharged sST2 values as a guide
Fabien Huet, Jean Nicoleau, Anne‐Marie Dupuy, Corentin Curinier, Cyril Breuker, Audrey Castet‐Nicolas, Manuela Lotierzo, Eran Kalmanovich, Laetitia Zerkowski, Mariama Akodad, Jérôme Adda, Audrey Agullo, Florence Leclercq, Jean‐Luc Pasquie, Pascal Battistella, Camille Roubille, Pierre Fesler, Grégoire Mercier, Guillaume Bourel, Jean‐Paul Cristol, François Roubille   +20 more
doaj   +1 more source

The pro-inflammatory marker soluble suppression of tumorigenicity-2 (ST2) is reduced especially in diabetic morbidly obese patients undergoing bariatric surgery

Cardiovascular Diabetology, 2020
Background High soluble suppression of tumorigenicity-2 (sST2) is a marker of poor prognosis in chronic inflammatory conditions. ST2 and its ligand interleukin (IL)-33 are elevated in adipose tissue of obese individuals.
Svitlana Demyanets, Christoph Kaun, Alexandra Kaider, Walter Speidl, Manfred Prager, Stanislav Oravec, Philipp Hohensinner, Johann Wojta, Gersina Rega-Kaun   +8 more
doaj   +1 more source

A Multi-marker Model for Predicting Decompensated Heart Failure in Patients with Prior Acute Myocardial Infarction [PDF]

, 2020
The aim of the study was to assess the prognostic value of determining the plasma concentration of NT-proBNP and ST2 in the patients with decompensated HF and prior acute myocardial infarction and their combination in this category of patients.Materials ...
Levandovska, K. (Khrystyna)
core   +3 more sources

Fates of endocytosed somatostatin sst2 receptors and associated agonists [PDF]

Biochemical Journal, 1998
Somatostatin agonists are rapidly and efficiently internalized with the somatostatin sst2 receptor. The fate of internalized agonists and receptors is of critical importance because the rate of ligand recycling back to the cell surface can limit the amount of radioligand accumulated inside the cells, whereas receptor recycling might be of vital ...
J A, Koenig, R, Kaur, I, Dodgeon, J M, Edwardson, P P, Humphrey   +4 more
openaire   +2 more sources

Increased systemic sST2 in patients with end stage renal disease contributes to milder liver damage during HCV infection

Journal of Infection in Developing Countries, 2020
Introduction: Hepatitis C Virus (HCV) is the leading cause of chronic liver disease and is a serious global health problem. Hepatitis C infection is highly prevalent in patients with end stage renal disease (ESRD), due to frequent exposure to blood and ...
Ruzica Lukic, Maja Cupic, Nevena Gajovic, Milena Jurisevic, Zeljko Mijailovic, Bojana Davidovic, Bojan Kujundzic, Bojan Joksimovic, Nebojsa Arsenijevic, Ivan Jovanovic   +9 more
doaj   +1 more source

Soluble ST2 levels and left ventricular structure and function in patients with metabolic syndrome [PDF]

, 2016
Background: A biomarker that is of great interest in relation to adverse cardiovascular events is soluble ST2 (sST2), a member of the interleukin family.
Beunza, Maite, Cardelli, Patrizia, Celic, Vera, Di Somma, Salvatore, Escribano, Elena, Floridi, Federico, Lopez-Andres, Natalia, Magrini, Laura, Majstorovic, Anka, Marino, Rossella, Melero, Amaia, Pencic-Popovic, Biljana, Roy, Ignacio, Salerno, Gerardo, Sljivic, Aleksandra   +14 more
core   +1 more source

Soluble ST2 concentrations associate with in-hospital mortality and need for mechanical ventilation in unselected patients with COVID-19

Open Heart, 2021
Objective Soluble ST2 (sST2) reflects inflammation, endothelial dysfunction and myocardial fibrosis, is produced in the lungs and is an established biomarker in heart failure.
Ingebjørg Seljeflot, Torbjørn Omland, Christian Prebensen, Christine Jonassen, My Svensson, Jan Erik Berdal, Peder Langeland Myhre   +6 more
doaj   +1 more source

The IL-33/sST2 Axis in Thromboangiitis Obliterans.

Journal of inflammation research, 2020
Until recently, it remains unknown whether thromboangiitis obliterans (TAO) is a type of systemic vasculitis. A high level of IL-33 and its soluble decoy receptor sST2 in the acute phase of systemic vasculitis has been demonstrated.The serum level of IL-33 and sST2 in 50 TAO patients, 20 age- and smoking habit-matched controls and 19 age-matched non ...
Sharebiani,Hiva, Moharreri,Mehran, Mirhosseini,Ali, Fazeli,Bahare   +3 more
openaire   +4 more sources